Journal article icon

Journal article

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

Abstract:

Introduction:
The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma therapy (CPT) trials in many countries, including the United Kingdom. Effective CPT is likely to require high titres of neutralising antibody (nAb) in convalescent donations. Understanding the relationship between function...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/tme.12746

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9154-4190
Expand authors...
Georg and Emily Von Opel Foundation More from this funder
European Research Council More from this funder
Publisher:
Wiley Publisher's website
Journal:
Transfusion Medicine Journal website
Volume:
31
Issue:
3
Pages:
167-175
Place of publication:
England
Publication date:
2020-12-17
Acceptance date:
2020-10-02
DOI:
EISSN:
1365-3148
ISSN:
0958-7578
Pmid:
33333627
Language:
English
Keywords:
Pubs id:
1150536
Local pid:
pubs:1150536
Deposit date:
2021-01-06

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP